Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

BACKGROUND: A dichotomous index combining two gene expression assays, HOXB13 : IL17BR (H : I) and molecular grade index (MGI), was developed to assess risk of recurrence in breast cancer patients. The study objective was to demonstrate the prognostic utility of the combined index in early-stage brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerevall, P-L, Ma, X-J, Li, H, Salunga, R, Kesty, N C, Erlander, M G, Sgroi, D C, Holmlund, B, Skoog, L, Fornander, T, Nordenskjöld, B, Stål, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111159/
https://www.ncbi.nlm.nih.gov/pubmed/21559019
http://dx.doi.org/10.1038/bjc.2011.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111159/
https://www.ncbi.nlm.nih.gov/pubmed/21559019
http://dx.doi.org/10.1038/bjc.2011.145

Ejemplares similares